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Abstract
Mammalian carboxylesterase (CES or Ces) genes encode enzymes that participate in xenobiotic,
drug, and lipid metabolism in the body and are members of at least five gene families. Tandem
duplications have added more genes for some families, particularly for mouse and rat genomes,
which has caused confusion in naming rodent Ces genes. This article describes a new
nomenclature system for human, mouse, and rat carboxylesterase genes that identifies homolog
gene families and allocates a unique name for each gene. The guidelines of human, mouse, and rat
gene nomenclature committees were followed and “CES” (human) and “Ces” (mouse and rat) root
symbols were used followed by the family number (e.g., human CES1). Where multiple genes
were identified for a family or where a clash occurred with an existing gene name, a letter was
added (e.g., human CES4A; mouse and rat Ces1a) that reflected gene relatedness among rodent
species (e.g., mouse and rat Ces1a). Pseudogenes were named by adding “P” and a number to the
human gene name (e.g., human CES1P1) or by using a new letter followed by ps for mouse and
rat Ces pseudogenes (e.g., Ces2d-ps). Gene transcript isoforms were named by adding the
GenBank accession ID to the gene symbol (e.g., human CES1_AB119995 or mouse
Ces1e_BC019208). This nomenclature improves our understanding of human, mouse, and rat
CES/Ces gene families and facilitates research into the structure, function, and evolution of these
gene families. It also serves as a model for naming CES genes from other mammalian species.
Introduction
Five families of mammalian carboxylesterases (CES; E.C.3.1.1.1) have been described,
including CES1, the major liver enzyme (Ghosh 2000; Holmes et al. 2009a; Munger et al.
1991; Shibita et al. 1993); CES2, the major intestinal enzyme (Holmes et al. 2009a;
Langmann et al. 1997; Schewer et al. 1997); CES3, expressed in brain, liver, and colon
(Holmes et al. 2010; Sanghani et al. 2004); CES5 (also called CES7 or cauxin), a major
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urinary protein of the domestic cat also present in human tissues (Holmes et al. 2008a;
Miyazaki et al. 2003, 2006; Zhang et al. 2009); and CES6, a predicted CES-like enzyme in
brain (Clark et al. 2003; Holmes et al. 2009a; reviewed by Williams et al. 2010). These
enzymes catalyze hydrolytic and transesterification reactions with xenobiotics, anticancer
prodrugs, and narcotics (Ohtsuka et al. 2003; Redinbo and Potter 2005; Satoh and Hosokawa
1998, 2006; Satoh et al. 2002), the conversion of lung alveolar surfactant (Ruppert et al.
2006), and several lipid metabolic reactions (Becker et al. 1994; Diczfalusy et al. 2001;
Ghosh 2000; Hosokawa et al. 2007; Tsujita and Okuda 1993); they may also assist with the
assembly of low-density lipoprotein particles in liver (Wang et al. 2007).
Structures for human and animal CES genes have been reported, including rodent CES1- and
CES2-“like” genes (Dolinsky et al. 2001; Ghosh et al. 1995; Hosokawa et al. 2007) and
human CES1 and CES2 genes (Becker et al. 1994; Ghosh 2000; Langmann et al. 1997;
Marsh et al. 2004). Predicted gene structures have been also described for the human CES3,
CES5, and CES6 genes, which are localized with CES1 and CES2 in two contiguous CES
gene clusters on human chromosome 16 (Holmes et al. 2008a, 2009a, b, 2010). In addition,
a CES1-like pseudogene (currently designated CES4) is located with the CES1–CES5 gene
cluster (Yan et al. 1999). Mammalian CES genes usually contain 12–14 exons of DNA
encoding CES enzyme sequences which may be shuffled during mRNA synthesis,
generating several CES transcripts and enzymes encoded by each of the CES genes (see
Thierry-Mieg and Thierry-Mieg 2006). There are significant sequence similarities for the
five CES families, especially for key regions previously identified for human liver CES1
(Bencharit et al. 2003, 2006; Fleming et al. 2005). Three-dimensional structural analyses of
human CES1 have identified three major ligand binding sites, including the broad-
specificity active site, the “side door,” and the “Z-site,” where substrates, fatty acids, and
cholesterol analogs, respectively, are bound; and an active site `gate', which may facilitate
product release following catalysis (Bencharit et al. 2003, 2006; Fleming et al. 2005).
Because of the confusion associated with the current nomenclature for mammalian CES
genes, particularly for mouse and rat Ces genes where significant gene duplication events
have generated a large number of Ces1-like and Ces2-like genes (Berning et al. 1985;
Dolinsky et al. 2001; Ghosh et al. 1995; Hosokawa et al. 2007; Satoh and Hosokawa 1995),
this article proposes a new nomenclature system that enables easy identification of CES
family members for this enzyme. The nomenclature follows the guidelines of the human,
mouse, and rat gene nomenclature committees and allocates a new name for each human
(CES) or mouse and rat (Ces) gene. It also names and identifies the gene family origin for
identified CES pseudogenes and provides a system for naming transcript iso-forms derived
from each of the CES genes. The nomenclature has the flexibility to accommodate new
human, mouse, and rat CES genes and will assist further research into the structure,
function, and evolution of these gene families as well as serve as a model for naming CES
genes from other mammalian species.
Guiding principles for the new CES nomenclature
The new nomenclature system for human, mouse, and rat CES genes and enzymes is based
on the identification of homolog gene families and a subsequent allocation of a unique gene
name for each of the genes observed from genome databases or reported from previous
studies. It follows the guidelines of the human, mouse, and rat gene nomenclature
committees and recommends the naming of homolog CES or Ces genes among species. The
italicized root symbol “CES” for human and “Ces” for mouse and rat genes were used,
followed by an number describing the gene family (examples include CES1 for human CES
family 1 or Ces1 for mouse and rat Ces family 1 genes) (Tables 1, 2, 3). For mammalian
genomes in which multiple genes were identified or a gene required a name that clashed
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with an existing name, a capital letter (for human genes) (e.g., CES4A) or a lower-case letter
(for mouse and rat genes) (e.g., Ces1a, Ces1b for multiple mouse Ces1-like genes) was
added after the number. The letter used for multiple genes reflected the relatedness of the
genes across species (e.g., reflecting higher degrees of identity for mouse and rat Ces1a
genes). When a human CES pseudogene was identified, a capital “P” and a number were
added to the gene name (e.g., CES1P1), whereas for mouse and rat Ces pseudogenes, a
unique lower-case letter was used followed by “-ps” (e.g., Ces2d-ps). Transcript iso-forms
of human (CES) and mouse and rat (Ces) gene transcripts were designated by following the
gene name with the GenBank transcript ID, such as human CES1_AB119997 and
CES1_AB187225, which differs from the current nomenclature used for human CES1 iso-
forms (CES1A1 and CES1A2, respectively) (see Table 1).
Human CES genes
Table 1 summarizes the locations and exonic structures for human CES genes based upon
previous reports for human CES1 and CES2 (Becker et al. 1994; Ghosh 2000; Langmann et
al. 1997; Marsh et al. 2004) and predictions for human CES3 (Holmes et al. 2010), CES4A
(Holmes et al. 2009a), and CES5A (Holmes et al. 2008a) [the February 2009 human
reference sequence (GRCh37) was used in this study (Rhead et al. 2010)]. Human CES1P1
(a CES1-like pseudogene), CES1, and CES5A were located in a cluster (cluster 1) on
chromosome 16, while CES2, CES3, and CES4A were in a separate cluster (cluster 2) on the
same chromosome. Cluster 1 CES genes (CES1 and CES5A) were transcribed on the
negative strand, whereas cluster 2 genes (CES2, CES3, and CES4A) were transcribed on the
positive strand. Figure 1 summarizes the predicted exonic start sites for human CES genes,
with CES1 and CES4A containing 14 exons, CES3 and CES5A 13 exons, and CES2 with 12
exons. These exon start sites were in identical or similar positions to those reported for
CES1 (Ghosh 2000; March et al. 2004). Figure 2 shows the comparative structures for
human CES reference sequences and transcripts described on the AceView website
(http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/) (Thierry-Mieg and Thierry-Mieg
2006). The CES gene and transcript sequences varied in size from 11 kb for CES2 to 79 kb
for CES5A and exhibited distinct structures in each case. Moreover, several isoforms were
generated in vivo for each of the human CES genes and have different structures as a result
of transcriptional events, including truncation of the 5' ends, differential presence or absence
of exons, alternative splicing or retention of introns, or overlapping exons with different
boundaries. In addition, the isoforms are differentially expressed in tissues of the body and
may perform distinctive metabolic roles. CES isoforms were named by using the gene name
followed by the GenBank ID for the specific transcript. Recent studies of human CES1 have
described at least two major isoform transcripts, designated as CES1A1 (AB119997) and
CES1A2 (AB119996) (Tanimoto et al. 2007). These isoforms have been redesignated as
CES1_AB119997 and CES1_AB119997, respectively (see Table 1) and encode sequences
that differ by only four amino acid residues within the N-terminal region (exon 1) (Tanimoto
et al. 2007). Distinct 5'-untranslated consensus sequences for binding transcription factors
were reported. They suggested differences in transcriptional regulation and functional roles
in contributing to CPT-11 chemosensitivity for these isoforms (Hosokawa et al. 2008;
Tanimoto et al. 2007; Yoshimura et al. 2008). Fukami et al. (2008) have also examined
human CES isoform structure and proposed that CES1P1,a CES1-like pseudogene on
chromosome 16 (designated as CES1A3), was derived from the CES1_AB119997 isoform.
human CES amino acid sequences and structures
An alignment of the amino acid sequences for human CES-like protein subunits is shown in
Fig. 1, together with a description of several features for these enzymes. The sequences have
been derived from previously reported sequences for CES1 (Munger et al. 1991; Shibata et
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al. 1993), CES2 (Langmann et al. 1997; Schewer et al. 1997), CES3 (Sanghani et al. 2004),
CES4A (previously CES6 or CES8) (Holmes et al. 2009a); and CES5A (previously CES7)
(Holmes et al. 2008a) (Table 1). Alignments of the human CES subunits showed between 39
and 46% sequence identities, which suggests that these are products of separate but related
gene families, whereas sequence alignments of human CES1 and CES2 with mouse CES1-
like and CES2-like subunits exhibited higher levels of sequence identities with the CES
family homolog in each case [66–78% identities for human and mouse CES1-like subunits
and 64–72% for human and mouse CES2-like subunits, respectively (data not shown)],
suggesting that these are members of the same mammalian CES families, in each case.
Similar results were observed for comparisons of human CES3, CES4A (previously CES6
or CES8), and CES5A (previously CES7) with the corresponding mouse CES homolog
sequences, with 65, 72, and 69% identities being observed, respectively. This supports the
designation of these CES genes as members of the same family, in each case.
The amino acid sequences for the human CES subunits examined contained 567 (CES1),
559 (CES2), 571 (CES3), 561 (CES4A), and 575 (CES5A) residues (Fig. 1). Previous
studies on human CES1 have identified key residues that contribute to the catalytic,
oligomeric, subcellular localization and regulatory functions for this enzyme (sequence
numbers refer to human CES1). These included the catalytic triad for the active site (Ser221;
Glu354; His468) (Cygler et al. 1993); disulfide bond-forming residues (Cys87/Cys116 and
Cys274/Cys285) (Lockridge et al. 1987); microsomal targeting sequences, including the
hydrophobic N-terminus signal peptide (Potter et al. 1998; von Heijne 1983; Zhen et al.
1995) and the C-terminal endoplasmic reticulum (ER) retention sequence (His-Ile-Glu-Leu)
(Robbi and Beaufay 1983); and ligand-binding sites, including the “Z-site” (Gly356),
the ”side door” (Val424-Met425-Phe426), and the “gate” (Phe550) residues (Bencharit et al.
2003, 2006; Fleming et al. 2005). Identical residues were observed for each of the human
CES subunit families for the active site triad and disulfide bond-forming residues, although
changes were observed for some key residues for CES1 subunits, including the “side-door”
and “gate” of the active site, with family-specific sequences or residues in each case. The
“Z-site” (Gly356 for human CES1) has been retained for human CES2 and CES5A
sequences, but substituted for CES3 (Ser) and CES4A (Asn). The hydrophobic N-terminal
sequence for human CES sequences has undergone major changes, although this region
retains a predicted signal peptide property. The human CES C-terminal tetrapeptide
sequences have also changed, although CES2 (HTEL) and CES3 (QEDL) are similar in
sequence with human CES1 (HIEL), which plays a role in the localization of human CES1
within endoplasmic reticulum membranes (Robbi and Beaufay 1983).
Other key human CES1 sequences included two charge clamps that are responsible for
subunit-subunit interaction, namely, residues Lys78/Glu183 and Glu72/Arg186, which
contribute to the trimeric and hexameric structures for this enzyme (Bencharit et al. 2003,
2006; Fleming et al. 2005). Other human CES subunit sequences for these charge clamp
sites included substitutions with neutral amino acids for the human CES2 and CES5A
sequences, while the CES3 and CES4A sequences retained one potential clamp site (Fig. 1).
Pindel et al. (1997) and Holmes et al. (2009b) have reported monomeric subunit structures
for human and baboon CES2, which is consistent with the absence of charge clamps for this
enzyme. This could have a major influence on the kinetics and biochemical roles for human
CES isozymes since three-dimensional studies have indicated that ligand binding to the
human CES1 “Z-site” shifts the trimer-hexamer equilibrium toward the trimer that facilitates
substrate binding and enzyme catalysis (Redinbo and Potter 2005). The N-glycosylation site
for human CES1 at Asn79-Ala80-Thr81 (Bencharit et al. 2003, 2006; Fleming et al. 2005;
Kroetz et al. 1993) was not retained for any of the other human CES sequences, although
potential N-glycosylation sites were observed at other positions, including CES2 (site 3),
CES3 (site 2), CES4A (sites 4, 5, and 7), and CES5A (sites 6, 8, and 9) (Table 4). Given the
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reported role of the N-glycosylated carbohydrate group contributing to CES1 stability and
maintaining catalytic efficiency (Kroetz et al. 1993), the N-glycosylation sites predicted for
other human CES subunits may perform similar functions or indeed may serve new
functions specific to a particular CES family.
Predicted secondary structures for human CES2 (Holmes et al. 2009b), CES3 (Holmes et al.
2010), CES4A (Holmes et al. 2009a), and CES5A (Holmes et al. 2008a) sequences were
compared with those reported for human CES1, and similar α-helix β-sheet structures were
observed for all of the CES subunits examined (Bencharit et al. 2003, 2006) (Fig. 1). This
was especially apparent near key residues or functional domains such as the α-helix within
the N-terminal signal peptide, the β-sheet and α-helix structures near the active site Ser221
(human CES1) and “Z-site” (Glu354/Gly356, respectively), the α-helices bordering the “side
door” site, and the a-helix containing the “gate” residue (Phe550 for human CES1). The
human CES5A sequence, however, contained a predicted helix at the hydrophobic C-
terminus not observed for other CES subunits which may perform a family-specific
function. Predicted 3D structures have been previously described for each of the human CES
subunits (Holmes et al. 2008a, 2009a, b, 2010); they were similar to the human CES1
structure (Bencharit et al. 2003, 2006).
Mouse Ces genes and enzymes
Table 2 summarizes the proposed names, locations, and overall structures for the Ces genes
observed for the mouse genome (July 2007 mouse [Mus musculus] genome data obtained
from the Build 37 assembly by NCBI and the Mouse Genome Sequencing Consortium)
(http://www.ncbi.nlm.nih.gov was used in this study). The italicized gene name Ces is
consistent with other mouse gene nomenclature and is preferred to the CES stem used for
human genes. At least 20 mouse Ces genes are recognized on the Mouse Genome Database
http://www.informatics.jax.org/) (MGI) and further described in terms of their locations on
mouse chromosome 8, the number of predicted exons for each gene, predicted strand for
transcription, number of amino acid residues and subunit molecular weights (MWs) for the
encoded CES subunits, and identification symbols from MGI (e.g., MGI3648919 for
Ces1a), NCBI (Reference Sequences were identified from the National Center for
Biotechnology Information database) (http://www.ncbi.nlm.nih.gov/), Vega (the VErtebrate
Genome Annotation database) (http://vega.sanger.ac.uk/index.html), UNIPROT (Universal
Protein Resource) (http://www.ebi.ac.uk/uniprot/), and Ensembl (Genome Database)
(http://www.ensembl.org/) database sources.
Eight Ces1-like genes are located in tandem within a 360-kb segment of mouse chromosome
8, with an average gene size of 28 kb. The names for these genes (Ces1a, Ces1b,…, Ces1h)
are allocated in the same order as their locations on the mouse genome (Table 3). The Ces1-
like gene cluster is also located near the mouse Ces5a gene, which is comparable to the
CES1P1-CES1-CES5A cluster observed for human chromosome 16. Each of these genes
contained 13 or 14 exons predicted for transcription on the negative strand and with encoded
CES subunits exhibiting distinct but similar amino acid sequences (554–567 residues). The
subunits were 63–85% identical with each other and with the human CES1 sequence, which
is consistent with these being members of the mouse Ces1 gene family. Mouse Ces1-like
genes included several that have been previously investigated, including Ces1c (previously
called Es1), encoding a major mouse plasma esterase with 554 amino acid residues and also
exhibiting lung surfactant convertase activity (Genetta et al. 1988; Krishnasamy et al. 1998);
Ces1d (previously Ces3), encoding a mouse liver enzyme with 565 residues and exhibiting
triacylglycerol hydrolase activity (Dolinsky et al. 2001); Ces1e (previously called Es22 or
egasyn), encoding a liver CES with 562 residues and exhibiting β-glucuronidase-binding
properties (Ovnic et al. 1991); and Ces1g (previously Ces1), encoding a liver CES with 565
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amino acid residues and exhibiting lipid metabolizing activity (Table 4) (Ellingham et al.
1998).
Eight Ces2-like genes were also observed in a second 286-kb gene cluster on mouse
chromosome 8, with an average gene size of approximately 8 kb (Table 2). These genes
were named according to their sequence of position on the mouse genome (Ces2a, Ces2b,
…, Ces2h) and included a pseudogene designated Ces2d-ps. Three of these mouse Ces2-like
genes have been previously described, including Ces2c (previously Ces2), encoding an
inducible liver acyl-carnitine hydrolase enzyme with 561 residues (Furihata et al. 2003);
Ces2e (previously Ces5), encoding a liver and intestinal enzyme with 560 amino acid
residues (The MGC Project Team 2004); and Ces2a (previously Ces6), encoding a liver and
colon enzyme with 558 residues (The MGC Project Team 2004). The Ces2-like cluster was
located alongside two Ces3-like mouse genes (Ces3a and Ces3b) and a Ces4a gene (Table
3); this is comparable to the CES2-CES3-CES4A gene cluster on human chromosome 16
(Table 1). The Ces3a gene (previously mouse esterase 31 or Est31) is expressed strongly in
male mouse livers and encodes a 554-residue CES3-like subunit (Aida et al. 1993), whereas
the Ces3b gene (previously Es31L or EG13909) is also expressed in liver and encodes a
568-residue subunit (The MGC Project Team 2004). The Ces4a gene (previously called
EST8 or Ces8) encodes an enzyme predicted for secretion in epidermal cells with 563 amino
acid residues and showing 72% identity with human CES4A (The MGC Project Team
2004).
Rat Ces genes and enzymes
Table 3 summarizes the proposed names, locations, and structures for Ces genes observed
for the rat genome [the November 2004 rat (Rattus norvegicus) genome assembly based on
version 3.4 produced by the Baylor Human Genome Sequencing Center (Gibbs et al. 2004)
was used in this study]. Fifteen rat Ces genes were identified on the Rat Genome Database
(RGD) (http://rgd.mcw.edu/) and further characterized by their locations on rat
chromosomes 1 and 19, the number of predicted exons for each gene, the predicted strand
for transcription, current gene symbols, the number of amino acid residues and subunit MWs
for the encoded CES subunits, and the identification symbols from RGD (e.g., RGD1583671
for Ces1a), NCBI Reference Sequences (http://www.ncbi.nlm.nih.gov/), Vega
(http://vega.sanger.ac.uk/index.html), UNIPROT (http://www.ebi.ac.uk/uniprot/), and
Ensembl (http://www.ensembl.org/) database sources.
Five Ces1-like genes were located in tandem within a 201-kb segment of rat chromosome
19, with an average gene size of 33 kb (Table 3). The names for these genes (Ces1a, Ces1c,
…, Ces1f) were allocated according to their degree of identity with the corresponding mouse
Ces1-like genes (Table 3). The genes were located in tandem in the same order as the mouse
Ces1-like genes and were near the rat Ces5a gene. This is comparable to the CES1P1–
CES1A–CES5A gene cluster observed for human chromosome 16. The rat Ces1-like genes
contained 14 exons and were predicted for transcription on the positive strand, with encoded
CES subunits exhibiting similar amino acid sequences (550–565 residues). The subunits
were 65–73% identical with each other and with the human CES1 sequence, which is
consistent with membership of the rat Ces1 gene family. The encoded rat Ces1-like subunit
sequences showed higher levels of identity with the corresponding mouse Ces1-like
sequences (81–92% for rat and mouse CES1a, CES1c, CES1d, CES1e, and CES1f amino
acid sequences). At least three rat Ces1-like genes have been previously described, including
Ces1c (previously called Es1), encoding a rat plasma esterase (Sanghani et al. 2002; Vanlith
et al. 1993); Ces1d (previously Ces3), encoding a rat liver enzyme with 565 residues and
exhibiting cholesteryl ester hydrolase activity (Ghosh et al. 1995; Robbi et al. 1990); and
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Ces1e (previously called ES-3 or egasyn), encoding a rat liver Ces with 561 residues and
having β-glucuronidase-binding properties (Robbi and Beaufay 1994).
Seven rat Ces2-like genes were observed on the rat genome and were localized on two
chromosomes: chromosome 1 (Ces2c and Ces2i) and chromosome 19 in three locations:
Ces2a and Ces2e; Ces2j; and Ces2g and Ces2h (Table 3). The genes were named according
to the degree of sequence identity with the corresponding mouse Ces2-like genes. Rat Ces2-
like genes have been previously investigated, including Ces2c (previously Ces2), encoding
an inducible liver acyl-carnitine hydrolase enzyme with 561 residues (Furihata et al. 2003);
Ces2e (previously Ces5), encoding a liver and intestinal enzyme with 560 amino acid
residues (The MGC Project Team 2004); and Ces2a (previously Ces6), encoding a liver and
colon enzyme with 558 residues.(The MGC Project Team 2004). The rat Ces2-like cluster
was located alongside a Ces3-like gene (Ces3a and Ces3b) and a Ces4a gene (Table 3),
which is comparable to the CES2A-CES3A-CES4A gene cluster on human chromosome 16
(Table 1).
Functions of mammalian CES families
Mammalian CES families exhibit broad substrate specificities, and specific roles for these
enzymes have been difficult to establish because of the promiscuity of the CES active site
toward a wide range of substrates and the existence of multiple forms with overlapping
specificities (Fleming et al. 2005; Imai 2006; Leinweber 1987; Redinbo and Potter 2005;
Satoh and Hosokawa 1998, 2006). Table 4 summarizes current knowledge concerning
substrates and functions reported for human, mouse, and rat CES gene family members.
Studies on human CES1 have examined its role in the metabolism of various drugs,
including narcotics such as heroin and cocaine (Bencharit et al. 2003; Pindel et al. 1997),
warfare nerve agents (Hemmert et al. 2010), psy-chostimulants (Sun et al. 2004), analgesics
(Takai et al. 1997), and chemotherapy drugs (Sanghani et al. 2004). Mammalian liver is
predominantly responsible for drug clearance from the body, with CES1 and CES2 (with
CES1 > CES2) playing major roles, following absorption of drugs into the circulation (Imai
2006; Pindel et al. 1997). Mammalian intestine (with CES2 > CES1) plays a major role in
first-pass clearance of several drugs, predominantly via CES2 in the ileum and jejunum
(Imai et al. 2003). CES1 and CES2 also have different roles in prodrug activation, as shown
for the anticancer drug irinotecan (CPT-11), which is converted to its active form SN-38
predominantly by CES2 (Humerickhouse et al. 2000). Recent modeling studies have shown
that the human CES2 active site cavity is lined with negatively charged residues; this may
explain the preference of this enzyme for neutral substrates (Vistoli et al. 2010). The role for
human CES3 has not been studied extensively, although the enzyme is capable of activating
prodrugs such as irinotecan (Sanghani et al. 2004). There are no reports concerning the
metabolic role(s) for human CES4A, and functional studies on mammalian CES5 function
are limited to feline species, where the enzyme is secreted into cat urine and apparently
regulates the production of a cat-specific amino acid “felinine,” a putative pheromone
precursor (Miyazaki et al. 2006).
Evolution of mammalian CES gene families
Recent comparative and evolutionary studies (Holmes et al. 2008b; Williams et al. 2010)
have concluded that there are at least five major mammalian CES gene families. In addition,
the gene duplication events that generated the ancestral mammalian CES1, CES2, CES3,
CES4, and CES5 genes have apparently predated the common ancestor for marsupial and
eutherian mammals (Holmes et al. 2008b) which has been estimated at approximately 173–
193 million years ago (Woodburne et al. 2003) and may coincide with the early
diversification of tetrapods approximately 350–360 million years ago (Donoghue and
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Benton 2007). The mammalian CES gene families are ancient in their genetic origins and
were established prior to the appearance of mammals during evolution. Further CES/Ces
gene duplication events have subsequently occurred during mammalian evolution, however,
especially for rodent species, for which the mouse and rat Ces1-like and Ces2-like genes
have apparently undergone successive duplication events. At least three of these are likely to
have occurred in the common ancestor for rat and mouse during rodent evolution since
several homolog genes and proteins were recognized, including Ces1c (previously Es1),
Ces1d (Ces3), Ces1e (Es22), Ces2a (Ces6), Ces2c (Ces2), and Ces2e (Ces5) (Tables 3, 4).
With the exception of the rat Ces2-like genes, which were located in multiple clusters on
chromosomes 1 and 19, human, mouse, and rat CES genes were localized within two
clusters of genes on the same chromosome, namely, Ces1–Ces5A (with multiple Ces1-like
genes) and Ces2–Ces3–Ces4A (with multiple Ces2-like genes in mouse and rat). The
presence of two Ces3-like genes in the mouse suggests that a further duplication event also
took place in this species.
Conclusions
This article has examined human, mouse, and rat carboxylesterase genes and encoded
subunits and has proposed a new nomenclature system, identifying each of five gene
families (designated as CES1, CES2,…, Ces5 for human genes and Ces1, Ces2,…, Ces5 for
mouse and rat genes) and allocating a unique gene name for each of the genes. The italicized
root symbol “CES” for human and “Ces” for mouse and rat genes followed by a number for
the family were used, which is consistent with current practice. When multiple genes were
identified for a gene family or where a gene required a name that clashed with an existing
name, a capital letter (for human genes) (e.g., CES4A) or a lower-case letter (for mouse and
rat genes) (e.g., Ces1a, Ces1b) was added after the number. A human CES pseudogene was
named, using a capital “P” and a number (e.g., CES1P1), whereas mouse and rat Ces
pseudogenes were named with a unique lower-case letter followed by “-ps” (e.g., Ces2d-ps).
This new nomenclature will also assist in naming multiple CES genes and proteins from
other mammalian species. As an example, Holmes et al. (2009c) and Williams et al. (2010)
have reported multiple CES1-like genes on the horse genome that may be designated in
accordance with the recommended nomenclature as CES1A, CES1B, CES1C, and so on, in
order of the tandem locations of these genes on chromosome 3. Transcript isoforms of CES
gene transcripts were named by following the gene name with the GenBank ID for the
specific transcript. This nomenclature will assist our understanding of the genetic
relatedness and the CES family origins for individual human, mouse, and rat CES genes and
proteins and facilitate future research into the structure, function, and evolution of these
genes. It will also serve as a model for naming CES genes from other mammalian species.
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Amino acid sequence alignments for human CES1, CES2, CES3, CES4A, and CES5A
subunits. See Table 1 for CES isoform sequences aligned. Asterisk identical residues for
CES subunits; colon similar alternate residues; dot dissimilar alternate residues. Signal
peptide sequences for CES1 (1–17), CES2 (1–25), CES3 (1–27), CES4A (1–19), and
CES5A (1–24) and C- termini (MTS) microsomal targeting sequences for CES1 (564–567),
CES2 (556–569), and CES3 (568–571) are shown in red. Active site (AS) triad residues
(human CES1) Ser221, Glu354, and His468 are highlighted in green. “Side door” (Val424-
Met425-Phe426), “Gate” (Phe550), and cholesterol binding residue (“Z site”) (Gly356) for
human CES1 (Fleming et al. 2005) are highlighted in khaki. Disulfide bond Cys residues for
human CES1 (filled circle) are shown in blue. Charge clamp residues identified for human
CES1 (Glu72…Arg186; Lys78…Glu183) (Fleming et al. 2005) are highlighted in purple.
Confirmed (CES1) (Asn79-Ala80-Thr81) [site 1] or predicted N-glycosylation sites for
human CES2 (Asn111-Met112-Thr113) [site 3]; CES3 (Asn105-Ser106-Ser107) [site 2];
CES4A (Asn213-Val214-Thr215) [site 4], Asn276-Ser-277-Thr278) [site 5], and Asn388-
Ile389-Thr390) [site 7]; and CES5A (Asn363-Lys364-Ser365) [site 6], (Asn513-Leu514-
Thr515) [site 8], and (Asn524-Met525-Ser526 [site 9] are highlighted in blue. α-Helix
(human CES1 or predicted) and β-sheet (human CES1 or predicted) regions are highlighted
in yellow and gray, respectively. α-Helices and β-sheets are numbered according to the
reported human CES1 3D structure (Fleming et al. 2005). Bold underlined font shows
known or predicted exon start sites; exon numbers refer to the human CES1 gene (see
Langmann et al. 1997). (Color figure online)
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Gene structures and major isoforms for human CES1, CES2, CES3, CES4A, and CES5A
genes. Derived from AceView website
http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/ (Thierry-Mieg and Thierry-Mieg
2006). Mature isoform variants (a) are shown with capped 5′ and 3′ ends for the predicted
mRNA sequences. Exons are in solid color. 5′ and 3′ untranslated regions of the genes are
shown as open boxes. Introns are shown as a line. The 5′ → 3′ transcription directions are
shown. a refers to the major transcript isoform for each human CES gene. Note that each
CES gene structure is drawn to a different scale and that the respective gene sizes are shown:
CES1, 34.8 kb; CES2, 10.9 kb; CES3, 13.9 kb; CES4A, 22.3 kb; and CES5A, 79.3 kb. (Color
figure online)
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Table 4
Functions and substrates for human CES and mouse and rat Ces genes and enzymes
Mammal CES (Ces) gene Current gene symbol(s) Substrates and function (hydrolysis or detoxification)
Human CES1 CES1, hCE-1, CES1A1, HU1 Heroin, cocaine1–3, methyl phenidate4, temocapril5, CPT-116, flurbiprofen7
CES1 Fatty acid ethyl ester synthase8, sarin9, ciclesonide10, cholesteryl ester
hydrolase11, triacylglycerol hydrolase11
CES2 CES2, hCE-2, HU2 Procaine5, heroin, cocaine1–3, temacapril5 , CPT-11,6 flurbiprofen7,
doxazolidine12
CES3 CES3 CPT-116
Mouse Ces1c Es1, Ces-N Lung surfactant convertase13, CPT-1114
Ces1d Ces3 Triacylglycerol hydrolase15
Ces1e Es22, egasyn β-glucuronidase binding in the liver endoplasmic reticulum16, retinyl ester
hydrolase26
Ces1f CesML1, TGH-2 Triacylglycerol hydrolase27, monoacylglycerol hydrolase27, cholesteryl ester
hydrolase27, phospholipase27
Ces1g Ces1 Lipid metabolism17
Ces2c Ces2 Inducible liver acylcarnitine hydrolase18
Rat Ces1c Es1 Retinyl palmitate19
Ces1d Ces3 Cholesterol ester hydrolase20, triacylglycerol hydrolase27, retinyl ester
hydrolase28
Ces1e ES-3 β-glucuronidase binding in the liver endoplasmic reticulum21
Ces2a Ces6 Intestinal first pass metabolism22
Ces2c Ces2 Inducible liver acylcarnitine hydrolase18, intestinal first pass metabolism22
Ces2e Ces5 Intestinal first pass metabolism22
Cat CES5A CES7, cauxin 3-Methylbutanol-cysteinylglycine hydrolysis in urine releasing pheromone23
Rat, sheep CES5A CES7, cauxin Lipid transfer reactions in epididymis24
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